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Abstract 
 After peripheral nerve injuries, the process of nerve regeneration and target reinnervation is very 
complex and depends on many different events occurring not only at the lesion site but also 
proximally and distally to it. In spite of the recent scientific and technological advancements, the 
need to find out new strategies to improve clinical nerve repair and regeneration remains. To 
reach this goal, the therapeutic strategy 
shouldthusexertitseffectsatdifferentlevelsinordertosimultaneouslypotentiateaxonal regeneration, 
increase neuronal survival, modulate central reorganization, and 
inhibitorreducetargetorganatrophy.Itisexpectedthatthismultilevelapproachmight 
leadtosignificantimprovementinthefunctionaloutcomeandthusthequalityoflifeof the patients 
suffering from peripheral nerve injury. 
 
1. INTRODUCTION 
Peripheral nerve injuries belong to the most challenging and difficult surgical reconstructive 
problems, and often cause partial or total loss of motor, sensory, and autonomic functions. The 
consequences of nerves injuries, which occur in approximately 2.8% of trauma patients 
(Huelsenbeck et al., 2012), may be disastrous and can result in substantial functional loss, thus 
interfering with many aspects of a person’s life because of permanently impaired sensory and 
motor functions. Moreover, development of secondary problems, such as neuropathic pain, 
dysesthesia, and cold intolerance is frequently observed following nerve injuries. In addition, 
nerve injuries have also a substantial economic impact on the society in terms of health care and 
long periods of sick leave (de Putter et al., 2012). Despite the ability of the peripheral nerve to 
regenerate and reinnervate denervated target organs has been recognized for more than a 
century, clinical and experimental evidences show that the regeneration is usually far from 
satisfactory, especially after severe injuries (Navarro, Vivo, & Valero-Cabre, 2007; Pfister et al., 
2011; Sun et al., 2009). So far, there is no technique to guarantee total recovery and normalization 
of functional sensibility following repair of an injured nerve. The poor outcome reflects the 
complexity of peripheral nerve injuries and the diversity of cellular and biochemical events, which 
are required to regain function. Indeed, a nerve injury differs from most other types of tissue 
injuries in the body, since it is not only a local repair process that is required. The processes of 
nerve regeneration and target reinnervation are complex, involving many factors which lead to 
immediate as well as long-term physiological, biochemical, and cellular changes (Fig. 
8.1)(Lundborg, 2005). First of all, dramatic changes occur at the level of the damaged nerve 
(Geuna et al., 2009). After a peripheral nerve traumatic lesion, at the level of the nerve injury, 
changes begin almost immediately, both proximally and distally to the lesion. In the proximal 
segment, axons degenerate for some distancebackfromthesiteofinjury.Withinhours 
afterinjury,theaxonproduces a great number of collateral sprouts that advance distally. After 
nerve transection, the distal segment undergoes a slow process of degeneration known as 
Wallerian degeneration, which starts immediately after injury and involves myelin breakdown and 
proliferation of Schwann cells. Schwann cells and macrophages are recruited to the injury site and 
phagocytize all the myelin and cellular debris. As the axon sprouts from the proximal stump, they 
regenerate between the layers of basal lamina of the Schwann cell processes reaching finally the 
target organs (Geuna et al., 2009). Second, changes occur to the target organ innervated by the 
damaged nerve (Geuna et al., 2009). The regenerated axon must reinnervate the proper target, 
and the target must retain the ability to accept reinnervation and recover from denervation-
related atrophy. Regeneration rate is approximately 1/2 mm/day; therefore, more proximal 
injuries lead to longer denervation periods and, despite optimal microsurgical techniques, the 
functional results achieved after repair of severed peripheral nerves are much less than optimal 
due to the target organ atrophy that takes place during the period of denervation. Third, changes 
occur to the proximal neural structures (e.g., dorsal root ganglia and spinal cord) where the cell 
bodies of the neurons are located. As a consequence of peripheral nerve injury, cell bodies in 
dorsal root ganglia (DRGs) and anterior horns of the spinal cord undergo adaptive changes that 
involve a chromatolytic reaction associated with a shift in protein synthesis from a “signaling 
mode” to a “growing mode” and protein synthesis switches from neurotransmitter-related 
substances to those required for axonal reconstruction. Moreover, the peripheral and central 
nervous systems (CNSs) are functionally integrated and a peripheral nerve lesion always results in 
long-lasting central modifications and reorganization (Kaas, 1991; Kaas & Collins, 2003; Wall, Xu, & 
Wang, 2002). The mechanisms of plasticity and reorganization of brain circuits that occur after 
nerve injury are complex; they may result in beneficial adaptive functional changes or contrarily 
cause maladaptive changes, such as pain, dysesthesia, hyperreflexia, and dystonia (Lundborg, 
2000, 2003). 
 
2. CHANGES AT THE NERVE LEVEL 
In 1943, Sir Herbert Seddon introduced a classification of three discrete types of nerve injury: 
neurapraxia, axonotmesis, and neurotmesis (Seddon, 1943): i. Neurapraxia is a mild injury 
characterized by local myelin damage. Axon continuity is preserved, and the nerve does not 
undergo Wallerian degeneration. It may result from exposure to a wide range of conditions such 
as heat, cold, irradiation, or electrical injuries, but is most commonly due to mechanical stress, 
such as concussion, compression, or traction injuries. Recovery may occur within hours, days, 
weeks, or up to a few months. ii. Axonotmesis involves additional damage to peripheral axons, but 
connective tissue structures remain intact. The interruption of axons is often the result of nerve 
pinching, crushing, or prolonged pressure. Wallerian degeneration occurs, but subsequent axonal 
regrowth may proceed along the intact endoneurial tubes. Recovery depends upon the degree of 
internal disorganization in the nerve aswell as the distance to the end organ. iii. Neurotmesis is the 
most severe injury, equivalent to physiologic disruption of the entire nerve. Functional recovery 
does not easily occur because of the extent of endoneurial tube disruption. Nonetheless, 
successful regeneration might result with surgical intervention. In 1951, Sunderland expanded 
Seddon’s classification to five degrees of peripheral nerve injury instead of three (Sunderland, 
1951). He divided Seddon’s axonotmesis grade into three types, depending on the degree of 
connective tissue involvement:  
i. Type 1 injury corresponds to Seddon’s neurapraxia with conduction block and completely 
intact stroma.  
ii. Type 2 injury corresponds to Seddon’s axonotmesis. The endoneurium, perineurium, and 
epineurium are still intact, but the axons are physiologically disrupted. Recovery can 
occur by axonal regrowth along endoneurial tubes, and complete functional recovery 
can be expected. The time for recovery depends on the level of injury, usually months.  
iii. In type 3 injury, the endoneurium is also disrupted, but the surrounding perineurium and 
epineurium are intact. Recovery is incomplete and depends upon how well the axons 
can cross the site of the lesion and find endoneurial tubes.  
iv. In type 4 injury, individual nerve fascicles are transected, and the continuity of the nerve 
trunk is maintained only by the surrounding epineurium. This type of injury requires 
surgical repair or reconstruction of the nerve.  
v. Type 5 injury is equivalent to Seddon’s neurotmesis (complete nerve disruption), and 
spontaneous recovery is negligible. Although Sunderland’s classification provides a 
concise and anatomic descriptionofnerve injury,the clinicalutility ofthis 
systemisdebatable since a nerve may undergo a combination of different degrees of 
injury. Therefore, a sixth degree of nerve injury has been introduced to define a 
combination of the other degrees of injuries (Mackinnon, 1989). After a peripheral 
nerve traumatic injury, complex pathophysiologic changes, including morphologic and 
metabolic changes, occur at the injury site almost immediately. The interruption of a 
peripheral nerve causes significant changes in normal morphology and tissue 
organization both proximally and distally to the lesion site. 
Thenervestumpdistaltothelesionundergoesadegenerationthatisnow known as 
“Wallerian degeneration” in honor of Augustus Volney Waller, who first characterized 
the disintegration of the frog glossopharyngeal and hypoglossal nerves after axotomy 
160 years ago (Stoll, Jander, & Myers, 2002). The process involves a number of phases, 
some concurrent, others consecutive, in which the distal portions of all affected axons 
degenerate. The sequence begins with prompt degradation of axoplasm, axolemma, 
and myelin sheath due to proteolysis (Lubinska, 1982; Schlaepfer, 1977; Vial, 1958). 
Then, the degraded myelin is phagocytized by the recruited macrophages to aid the 
removal of axonal and myelin debris (Bruck, 1997; Vargas & Barres, 2007). 
Fragmentation of axons is first detected few hours after nerve transection. Within 48 h, 
the entire nerve is fully involved, and over a period of 3–6 weeks, Schwann cells and 
macrophages phagocytize all the myelin and cellular debris. Schwann cells play several 
important roles in nerve degeneration and regeneration:  
i. Coincident with axonal injury, Schwann cells in the distal nerve begin to 
dedifferentiate (Lee et al., 2009). Within 48 h of injury, they start altering their 
gene expression: expression of myelin proteins (e.g., P0, MAG (myelin-
associated glycoprotein)) (Trapp, Hauer, & Lemke, 1988; White et al., 1989) and 
connexin 32 (a gap junction protein which forms reflexive contacts within 
individual myelinating SCs at para-nodes) (Hall, 2001) decreases dramatically as 
a consequence of axonal degeneration distal to the injury site, whereas 
regeneration associated genes (GAP-43), neurotrophic factors and their 
receptors, neurotrophin 4/5 (NT-4/5) neuregulin and its receptors, including the 
low-affinity neurotrophin receptor p75NTR; nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF), glial cell linederived neurotrophic factor 
(GDNF), and insulin-like growth factors (IGFs) (Carroll, Miller, Frohnert, Kim, & 
Corbett, 1997; Hall, 2001) are upregulated. 
ii. Between days 1 and 5 after injury, Schwann cells start proliferating, a critical event 
for the promotion of axonal regeneration. Their peak of activation occurs 
around day 3 postinjury and then decreases during the following weeks. A 
second phase of proliferation occurs during the regenerative process. 
Proliferating Schwann cells align in columns known as bands of Bu ¨ngner, 
which provide a supportive substrate and growth factors for regenerating axons 
(Griffin & Thompson, 2008; Stoll, Griffin, Li, & Trapp, 1989).  
iii. Schwann cells also play an important role in removing myelin debris; rapid 
clearance of myelin appears to be the most important precondition for axonal 
regeneration after peripheral nerve injury because it contains molecules that 
are inhibitory to axonal growth, such as MAG and oligodendrocyte-myelin 
glycoprotein (Huang et al., 2005; Shen et al., 2000). iv. Yet, Schwann cells in the 
distal nerve stump produce several neurotrophic and neurotropic molecules 
(such as NGF, BDNF, NT-4, GDNF, and insulin-like growth factor-1 (IGF-1)) that 
promote axon growth (Chen, Yu, & Strickland, 2007). Moreover, denervated Schwann 
cells overexpress fibronectin, laminin, tenascin, and some proteoglycans, whichcreatea 
substratefor axonal elongation. The phenotype of reactive Schwann cells resembles the 
one of immature Schwann cells, and they form a permissive substrate for regeneration. 
When these cells regain contact with the axons, they redifferentiate again (Jessen & 
Mirsky, 2008). 
Wallerian degeneration represents the basis for the nerve regeneration and target reinnervation 
processes (Battiston, Geuna, Ferrero, & Tos, 2005; Schmidt & Leach, 2003; Terzis, Sun, & Thanos, 
1997). In severe injuries, nerve regeneration begins only after Wallerian degeneration has run its 
course, but in mild injuries, the regenerative and repair processes begin almost immediately. The 
rate of axonal regrowth is determined by changes within the cell body, the activity of the 
specialized growth cone at the tip of each axon sprout, and the resistance of the injured tissue 
between cell body and end organ. Regenerating axons are usually produced at the node of Ranvier 
located close to the proximal stump of the lesion (Hopkins & Slack, 1981; McQuarrie, 1985). Nodal 
sprouts usually contain vesicles of various sizes, and as the sprouts develop into well-formed 
growth cones, the number of vesicles markedly increases. Sprouts from the node of Ranvier 
extend through their own basal lamina tubes in the proximal segment, traverse the narrow gap of 
connective tissue between the proximal and distal stumps, and finally enter the distal nerve 
segment. During extension through the Schwann cell column, regenerating axons grow along the 
Schwann cell basal lamina. Axon–Schwann cell attachment is mediated by various adhesion 
molecules including the immunoglobulin superfamily, for example, neural cell adhesion molecule 
(N-CAM) and L1, and the cadherin superfamily, for example, N-cadherin and E-cadherin, whereas 
axon basal lamina contact is for the most part mediated by laminin (Letourneau, Condic, & Snow, 
1994). These adhesion molecules are no longer detected when Schwann cells begin to form the 
myelin sheath around the axon, whereas the mature unmyelinated fibers continue to exhibit such 
adhesion molecules (Ide, 1996). When surgical repair of the nerve is required, the goal is to guide 
regenerating sensory, motor, and autonomic axons to the distal nerve segment to maximize the 
chance of target reinnervation (Pfister et al., 2011). Nerve reconstruction by tissue engineering has 
seen an increasing interest over the past years (Leach & Schmidt, 2005; Pfister et al., 2011). 
Despite the spontaneous regeneration potential of peripheral nerves and the best efforts and 
modern surgical techniques, functional restoration is often incomplete and clinical results are still 
unsatisfactory (Battiston et al., 2009; Scholz et al., 2009). Peripheral nerve injury may result in 
injury without gaps or injury with gaps between the nerve stumps. When there is no gap or the 
gap is short (5 mm or less), as in simple injuries, the common surgical approach is a direct suture 
of the two stumps (end-to-end suture) (Terzis et al., 1997). For longer nerve gaps, when nerve 
injury resulted in substance loss between the two nerve stumps, this direct suturing under tension 
leads to very poor clinical results (Dvali & Mackinnon, 2003) and a segment of nerve or other 
materials must be used to bridge the gap. The demonstration, in the early 1970s, that grafting of 
an autogenous nerve segment to bridge a nerve defect leads to better clinical results than suturing 
the two stumps under tension (Millesi, 1970), opened a new era in peripheral nerve surgery 
making it possibly the most successful surgical approach to complex lesions that before would 
have been unfathomable. There are three types of conventional bridging materials:  
i. Autologous nerve grafts. Nerve autografts have seen extensive clinical employment over 
the past 30 years. A nerve graft providesan ideal conduit for regenerating axons 
because it provides a scaffold which contains Schwann cell basal laminae, and 
moreover, these Schwann cells produce growth factors (Lundborg, 2004). Autogenous 
nerve grafting can be performed with nonvascularized autogenous nerve, vascularized 
nerve, interpositional conduits, and nerve allografts. However, it has several 
disadvantages, including an extra incision for the removal of a healthy sensory nerve, 
and the removal of a healthy sensory nerve whichwill result ina sensory deficit. Finally, 
donorgraft material islimited, particularly for managing extensive lesions which require 
several lengths of nerve graft.  
ii. Non-nervous biological grafts. Conduits made by small segments of an artery were first 
successfully employed by Bungner (Bungner, 1891). However, interest shifted then to 
veins for their larger availability and reduced side effects related to their withdrawal 
(Wrede, 1909). Similartoveins,alsotheuseofskeletalmuscleautograftsfornerverepair 
wasalready reported many years ago (Fawcett & Keynes, 1990; Keynes, Hopkins, & 
Huang, 1984). The idea of employing muscle fibers for axonal regeneration is on the 
similarities between the muscle basal lamina and the endoneurial tubes (Fawcett & 
Keynes, 1990; Glasby, Gschmeissner, Hitchcock, & Huang, 1986). Finally, a combined 
conduit by enriching vein segments with fresh skeletal muscle fibers (muscle-in-vein 
conduit) is used to improve effectiveness of tubulization nerve repair (Battiston, Tos, 
Cushway, & Geuna, 2000; Battiston, Tos, Geuna, Giacobini-Robecchi, & Guglielmone, 
2000; Brunelli, Battiston, Vigasio, Brunelli, & Marocolo, 1993; Fornaro, Tos, Geuna, 
Giacobini-Robecchi, & Battiston, 2001; Tos, Battiston, Ciclamini, Geuna, & Artiaco, 
2012). 
iii. Non-biological grafts. The use of non-biological materials for nerve reconstruction has a 
lengthy history started at the beginning of the twentieth century, and many attempts 
to use various nonbiological materials, such as metals, permeable cellulose esters, 
gelatine tubes, rubber, plastics, etc., were carried out (Fields, Le Beau, Longo, & 
Ellisman, 1989). The past 30 years saw an impressive increase of experimental studies 
aimed at testing new biomaterials for nerve regeneration, such as decalcified silicone 
tube, bone tube, nylon fiber tube, polyurethanes, etc.(Battistonet al., 2005; Pfister, 
Papaloizos, Merkle, &Gander,2007; Schmidt & Leach, 2003). The results have been in 
general very successful, and their effectiveness is similar and sometimes even superior 
to traditional nerve autografts (Navarro et al., 1996; Yannas & Hill, 2004; Young, 
Wiberg, & Terenghi, 2002).  
Moreover, direct neurotization of denervated muscles is used in situations where the motor 
nerve has been avulsed and direct nerve suture or grafting is not possible (Brunelli, 2005). It 
has been demonstrated that an axon that is in contact with a denervated muscular fiber can 
form a new neuromuscular junction (NMJ). A prerequisite for this procedure is that there is 
some residual trophism of the muscle. Generally, however, neurotization procedures have 
poor functional outcome. Finally, end-to-side neurorrhaphy is based on the assumption that an 
intact nerve can “donate” axons to the distal end of an injured nerve (Papalia et al., 2003). This 
technique has received particular interest when the nerve gap is large or when the lesion is 
proximal, both of which severely limit nerve regeneration. 
 
3. CHANGES OCCURRING DISTALLY TO THE DAMAGED NERVE: FOCUS ON SKELETAL MUSCLE 
Target organ atrophy might represent a limiting factor in functional recovery after nerve repair 
and regeneration. Among the different sensory and motor target organs, skeletal muscles 
represent the most important ones in terms of clinical relevance. The normal structural and 
functional integrity of skeletal muscle depends on intact innervation, normal transmission of 
impulses across the myoneural junction, and normal metabolic processes within the muscle cell. 
Injury to peripheral nerves always results in immediate loss of muscle function and progressive 
skeletal muscle atrophy, thus representing an important cause of poor clinical results after nerve 
reconstruction. Following a peripheral nerve injury, the longer the interval between denervation 
and reinnervation, the poorer the degree of motor recovery; thus, the regenerative outcome may 
be very poor when reinnervation of denervated target organs is delayed due either to a long 
distance between target and lesion site or to delayed nerve repair following major trauma (Birch & 
Raji, 1991; Merle, Bour, Foucher, & Saint Laurent, 1986). Since axons usually regrow at an average 
rate of 1 mm/day (Buchthal & Kuhl, 1979; Seddon & Fynn, 1972), it would take a long time for the 
muscle to be reinnervated. The success of reinnervation depends therefore both on the ability of 
the neuron to reprogram its growth and to establish new connections, and on the ability of muscle 
fibers to survive in the absence of trophic and regulating signals derived from the nerve. 
Denervated muscles come across structural, biochemical, and physiological changes eventually 
leading to atrophy and apoptosis, losing up to 80% of their mass (Gutmann, 1962). Over time, 
denervated muscles lose receptiveness to regenerated motor axons that reach the muscle 
because of a significant loss of viable muscle cells due to fiber necrosis, connective tissue 
hyperplasia, and exhaustion of satellite cell regeneration (Fu & Gordon, 1995; Irintchev, Draguhn, 
& Wernig, 1990; Schmalbruch, al-Amood, & Lewis, 1991; Veltri, Kwiecien, Minet, Fahnestock, & 
Bain, 2005). The loss of neural input, including neurotransmitters, neurotrophic factors, and other 
signals, promotes muscle fiber atrophy and thus reduces receptivity to regenerated axons (Veltri 
et al., 2005). Moreover, in response to an injury, satellite cells undergo a period of rapid 
proliferation; the majority of the satellite cells differentiate and fuse to form new myofibers or to 
repair the damagedones(Lu,Huang,&Carlson,1997;Schultz, Jaryszak,&Valliere,1985). During early 
stages, denervated muscle shows also a wide spectrum of molecular and cellular changes, 
including changes in gene expression. Upon denervation, there is the upregulation of NGF, BDNF 
(Zhao, Veltri, Li, Bain, & Fahnestock, 2004), IGF (Tang, Cheung, Ip, & Ip, 2000), fibroblast growth 
factor (FGF), hepatocyte growth factor (Yamaguchi, Ishii, Morita, Oota, & Takeda, 2004), and the 
alpha component of ciliary neurotrophic factor (CNTF) receptor complex (Tang et al., 2000). Also, 
the expression of many metabolic molecules, such as ferritin heavy chain, adhesion molecules, 
such as N-CAM, and extracellular proteases, including urokinase, change in response to muscle 
denervation. Finally, an increase in the level of ErbB2 and ErbB3 receptors and Neuregulin1 
expression was also demonstrated (Ng, Pun, Yang, Ip, & Tsim, 1997; Nicolino et al., 2009; Suarez et 
al., 2001). These adaptive changes might act to maintain muscle fiber survival during early stages 
of denervation and participate in the remodeling of neuromuscular synapse (Tang et al., 2000). 
Traditional strategies to improve motor functional recovery after injury by delaying the effects of 
the denervation process include electrical stimulation and rehabilitation of the denervated 
muscles (Nicolaidis & Williams, 2001). These treatments can improve muscle function after nerve 
injury in the clinical setting; however, they are not very effective in arresting denervated muscle 
atrophy and patient compliance is often poor; moreover, implantable electrical systems are 
expensive. Microsurgical repair within 2 months of injury can essentially reverse skeletal muscle 
changes and result in good functional recovery (Finkelstein, Dooley, & Luff, 1993). In contrast, if 
surgery is delayed for 6 months or more, denervation results in irreversible structural damage, 
including extrafusal fiber necrosis, connective tissue hyperplasia, and deterioration of the muscle 
spindles, leading to poor reinnervation and functional recovery (Bain, Veltri, Chamberlain, & 
Fahnestock, 2001; Hynes, Bain, Thoma, Veltri, & Maguire, 1997; Veltri et al., 2005). Furthermore, 
even when nerve surgery is performed early, there will still be a long period of muscle denervation 
if the distance from the site of injury is substantial, and the operative results are likely to be 
correspondingly poor. Auseful strategy to delay the skeletal muscle atrophy might be toconnect 
the end of a sensory nerve to the side of the distal nerve stump of the injured nerve (sensory 
protection) in order to maintain the structural and functional integrity of muscle until axons of the 
native nerve reach their target (Bain et al., 2001; Hynes et al., 1997; Irintchev et al., 1990; Veltri et 
al., 2005; Wang, Gu, Xu, Shen, & Li, 2001). This strategy uses a readily available sensory nerve to 
directly or indirectly support denervated muscle fibers by the supply of trophic factors, improve 
existing endoneurial sheath structure, and enhance regeneration by the native nerve (Veltri et al., 
2005; Zhao et al., 2004). It has been shown that sensory protection minimizes two of the three 
major structural consequences of chronic denervation: fiber necrosis and connective tissue 
hyperplasia. 
Anothersolutiontodelaythedenervatedatrophyofskeletalmusclesisthe use of neural stem cells 
(NSCs); recent studies have reported that genetically modified NSCs ameliorate experimental 
spinal muscular atrophy, providing neurotrophic support or partially replacing interrupted 
innervation between neural cells and skeletal muscles (Corti et al., 2006, 2009). Embryonic stem 
cellstransplantedintothespinalcordcoulddifferentiateintorelativelynormal motor neurons, extend 
axons into periphery nerves, and form new NMJs with denervated muscles (Deshpande et al., 
2006; Gao, Coggeshall, Tarasenko,&Wu,2005;Lee,Tos,etal., 2007;Lee,Jeyakumar,etal.,2007). 
Finally, local and/or systemic administration of various molecules might also prevent skeletal 
muscle atrophy, such as IGF-1 (Latres et al., 2005; Yoshida, Semprun-Prieto, Sukhanov, & 
Delafontaine, 2010) and ghrelin (Porporato et al., 2013). 
 
4. CHANGES OCCURRING PROXIMALLY TO THE DAMAGED NERVE  
 
4.1. Changes in the DRGs after peripheral nerve injury and regeneration  
 
Anatomically, the DRGs are located along the dorsal spinal roots; they house the cell bodies of 
primary afferents of the spinal sensory system and are surrounded by a thick connective capsule. 
As a consequence of a peripheral nerve injury, trophic support from the periphery is blocked and 
DRG neuron cell bodies undergo adaptive changes: Nissl bodies (i.e., the basophilic 
neurotransmitter synthetic machinery) undergo dissolution, which is followed by a prominent 
migration of the nucleus from the center of the cell toward the periphery, an increase in the size 
of the nucleolus, nucleus, and cell body, cell swelling, and retraction of dendrites, which 
collectively are called “chromatolytic changes” (Fenrich & Gordon, 2004; Lieberman, 1971). The 
disappearance of the prominent basophilic-stained Nissl granules is particularly evident. These 
granules are ribosome clusters of rough endoplasmic reticulum, that is not observed after 
axotomy, when they become disorganized, freeing polyribosomes and ribonucleotides into the 
cytoplasm. The severity and the time course of the chromatolytic process are mainly influenced by 
the severity of the injury, the distance of lesion to cell body, the type of neuron, and the age 
(Navarro et al., 2007). The dissolution of the ribosomes and ordered arrays of rough endoplasmic 
reticulum that constitute the Nissl bodies are then accompanied by metabolic changes including 
overall increases in protein and mRNA synthesis as well as changes in the pattern genes that the 
neuron expresses. The main metabolic activity of the cell is shifted from synthesizing 
neurotransmitterrelated proteins to the synthesis of structural materials needed for axon repair 
and growth. For example, choline acetyltransferase is downregulated, whereas the neuropeptide, 
calcitonin gene-related peptide, the fast transported growth-associated protein, GAP-43, and the 
slowly transported cytoskeletal proteins, actin and tubulin, are upregulated (Haas, Donath, & 
Kreutzberg, 1993; Tetzlaff, Gilad, Leonard, Bisby, & Gilad, 1988). Glucose-6-phosphate 
dehydrogenase and hydrolytic enzyme are also upregulated (Davis, Taylor, & Anastakis, 2011; 
Fawcett & Keynes, 1990). The success of nerve regeneration and functional reinnervation of 
targets first depend on the capacity of axotomized neurons to survive and shift toward the 
regenerative phenotype (Navarro et al., 2007). Results of studies on the changes in DRG neuron 
number following a nerve injury show a wide variation in results. Most of the authors report that 
peripheral nerve transection induces the primary sensory neuronal death (Himes & Tessler, 1989; 
Terenghi, 1999; Vestergaard, Tandrup, & Jakobsen, 1997), showing that between 7% and 50% of 
primary sensory neurons (more small than large neurons) die after injury (Himes & Tessler, 1989; 
McKay Hart, Brannstrom, Wiberg, & Terenghi, 2002). Other authors report no significant neuron 
loss (Swett, Hong,& Miller,1995) orno detectable lossof dorsalroot axons until 4 months 
(Coggeshall, Lekan, Doubell, Allchorne, & Woolf, 1997; Cohen, Yachnis, Arai, Davis, & Scherer, 
1992) after injury to the spinal or sciatic nerve. Further, during regeneration, the cell body 
undergoes visible changes that mark the reversal of chromatolysis. Indeed, the nucleus returns to 
the cell center and nucleoproteins reorganize into the compact Nissl granules. Acomplex 
andincompletely understoodinteraction occursbetweenthe cell body and the regenerating axon 
tip. Axoplasm, which serves to regenerate the axon tip, arises from the proximal axon segment 
and cell body. Both fast and slow components of axoplasmic transport supply materials from the 
cell body to the sites of axonal regeneration. The rate of increase in protein and lipid synthesis in 
the cell body influences the rate of advance and the final caliber of the regenerating axon (Burnett 
& Zager, 2004). 
 
4.2. CNS plasticity induced by peripheral nerve injury and regeneration  
Until recently, it was thought that no new neural connections could be formed in the adult brain 
(Kandel & Squire, 2000). It was assumed that, once connections had been established in foetal life, 
they hardly changed in adulthood. The only areas of the adult brain capable of reorganization 
were those involved in learning and memory processes. The picture has changed radically in the 
past decades; indeed, recent evidence demonstrates that the brain is capable of remarkable and 
widespread adaptive changes in response to peripheral injuries (Davis et al., 2011; Jain, Florence, 
& Kaas, 1998; Navarro et al., 2007). In fact, an injured nerve stops to function normally and this 
occurrence results in the reorganization of the projections to the CNS. While it is likely that this 
reorganization following injury takes place in the cortex, plastic changes may also occur in 
subcortical structures such as the thalamus, brainstem relay nuclei, and spinal cord (Lewin & 
McMahon, 1993). Plasticity of central connections may be positive, that is, compensate the lack in 
target reinnervation, but may also result in maladaptive changes, such as neuropathic pain, 
hyperreflexia, dystonia, and phantom limb awareness (Navarro et al., 2007). The response of the 
CNS to altered peripheral inputs may take many forms and include changes in ongoing or stimulus-
evoked activity, neurochemical changes, functional alterations of excitatory and inhibitory 
connections, atrophy and degeneration of normal substrates, sprouting of new connections, and 
reorganization of somatosensory and motor maps (Davis et al., 2011; Navarro et al., 2007). 
Plasticity of the somatosensory system has been extensively studied, and it has been shown that 
dramatic changes in the organization of cortical topography of the S1 area (primary 
somatosensory cortex) occur in response to a peripheral nerve injury (Donoghue & Sanes, 1987). It 
has been demonstrated that following peripheral nerve lesion in adult monkeys, the area in the 
somatosensory cortex corresponding to the deafferented body parts of the S1 became 
responsiveto inputs from neighboring body parts (Merzenich et al., 1983). Although this form of 
cortical plasticity is well documented across several sensory systems and in several species, such 
as cats, raccoons, rodents, and bats, the understanding of the underlying mechanisms remains an 
active area of research (Pelled, Chuang, Dodd, & Koretsky, 2007). In the motor system, changes in 
cortical representation also occur after peripheral injury; following amputation or peripheral nerve 
lesions, the area from which stimulation evoked movements of the adjacent body parts enlarged 
and the threshold for eliciting these movements is reduced (Donoghue & Sanes, 1988; Sanes, 
Suner, & Donoghue, 1990). The hypothesis that also visceral afferents exert a significant influence 
on the CNS plasticity has been investigated by many researchers, even if little is known. Recent 
studies have showed that vagus nerve stimulation (VNS, a well-established adjunctive treatment 
for intractable epilepsy and treatmentresistant depression) can induce neurogenesis 
andplasticityin the hippocampus (Biggio et al., 2009). In particular, it was demonstrated that acute 
VNS induces cell proliferation in the dentate gyrus of the adult rat hippocampus and an increase of 
both the total amount of doublecortin (DCX) immunoreactivity and the number of DCX-positive 
neurons in the dentate gyrus. In contrast, chronic VNS induced an increase of the BDNF 
expression, which may serve to promote and maintain new neuronal connections formed in 
response to chronic VNS (Biggio et al., 2009). Moreover, it was shown that acute VNS increased 
the expression ofgenes for BDNFand basic FGF in the rat hippocampus, both of which are 
important modulators of hippocampal plasticity and neurogenesis (Follesa et al., 2007). Finally, a 
recent study showed that damage to the subdiaphragmatic vagus in adult rats is followed by 
microglia activation and long-lasting changes in the dentate gyrus, leading to alteration of 
neurogenesis (Ronchi, Ryu, Fornaro, & Czaja, 2012). 
 
5. HOWTOSTUDYPERIPHERALNERVEREGENERATION? 
 
Essential progress in peripheral nerve regeneration research has been possible using animal 
models which may simulate anatomical, physiological, and behavioral aspects of the regenerative 
process. The experimental models available can be divided into three main groups according to (i) 
the animal model, (ii) the localization of lesion, and (iii) the type of lesion. By far, in nerve 
regeneration studies, the most employed laboratory animals are rats. The main reason appears to 
be the larger physical size of rat nerves compared to mouse nerves, which reduces the complexity 
of the microsurgical procedures (Tos et al., 2008), the possibility to have standardized and 
comparable functional tests and the fact that rats are more resilient than mice. On the other hand, 
the availability of genetically modified mouse colonies will probably increase mouse employment 
since transgenic models will allow to elucidate the role of a particular gene or protein in the 
mechanisms of the nerve regeneration process. In addition to these models, various large animal 
models have been employed including rabbits, sheep, pigs, and primates because several authors 
believe that the translation to clinical application may benefit from a preclinical study on large 
animal nerves since the regeneration process of nerves in large animals is more similar to humans 
(Fullarton, Lenihan, Myles, & Glasby, 2000). 
Accordingtothelocalizationofthelesion,untilrecently,mostperipheral 
nerveregenerationstudieshadbeenmainlycarriedoutontheratsciaticnerve model, primarily because 
it is the largest peripheral nerve (Baptista et al., 2007; Luis et al., 2007; Varejao et al., 2004). 
However, since most of the human peripheral nerve injuries affect the upper extremity, the 
necessity ofanexperimentalmodelclosertoclinicalinterestsisrequired.Indeed,recent years have 
shown an increasing interest toward the employment of major forelimb nerves (Geuna et al., 
2007; Papalia, Tos, Scevola, Raimondo, & Geuna, 2006; Papalia, Tos, Stagno d’Alcontres, Battiston, 
& Geuna, 2003; Sinis et al., 2008; Tos et al., 2009). In particular, the median nerve attracted the 
attention of peripheral nerve researchers because of the availability of an easier and more reliable 
behavioral test (the grasping test) (Lee, Tos, et al., 2007; Papalia et al., 2003; Tos et al., 2007). 
According to the type of lesion, so far, two main experimental lesion paradigms have been 
adopted for nerve regeneration studies: (1) axonotmesis (crush), which is characterized by 
complete interruption of nerve fibers continuity without discontinuingthe nerve, and(2) 
neurotmesis,which is a complete transection of the whole nerve. The complete nerve transection 
requires surgicalrepairtoreestablishepineurialcontinuity.Thisexperimentalparadigm provides not 
only the model for the comparative investigation of new types of microsurgical and tissue 
engineering approaches for nerve reconstruction but also a good model for assessing the 
effectiveness of various postoperative treatments (drugs, physical therapy, diet, etc.). On the 
other hand, with a crush lesion, the injured axons are provided with an optimal regeneration 
pathway, represented bythenerve segmentdistal totheinjury,without the need for the 
microsurgical repair. This experimental approach is therefore less technically challenging and is 
particularly suitable when a reproducible regeneration process is required, such as for the study of 
the biological mechanisms of regeneration or rationale development for new therapeutic agents. 
Recent advances in molecular neurobiology include the development of transgenic mice that have 
been used in multiple areas, including the field of developmental neurobiology and disease 
processes such as cancer and diabetes, but their use has extended also to the study of peripheral 
nerve regeneration subsequent to traumatic injuries. In particular, knockout mice, which carry a 
targeted gene inactivated through genetic engineering, are useful to elucidate the role of a 
particular gene or protein in a physiologic pathway by evaluating the consequences of its 
inactivation. On the other hand, transgenic animals that overexpress a particular gene or proteins 
are available, thus circumventing methodological difficulties in drug delivery, maintenance of 
constant neurotrophic factor concentrations, and the comorbidities associated with achieving 
these aims. Moreover, the availability of conditional knockout mice whose mutations can be 
targeted both spatially and temporally obviate the problem that some homozygous knockout mice 
can be embryonically lethal, thus limiting their usefulness. In addition, emerging tools include mice 
the axons or Schwann cells of which express fluorescent chromophores, which enabled new 
experiments with direct visualization of nerve regeneration over time. Inthe past years, many 
studiesof peripheralnerve regeneration have used knockout animals to elucidate the role of 
different neurotrophic factors during the process. For example, it has been shown that animals 
lacking CNTF are unable to produce motor nerve terminal sprouts after nerve transection or 
botulinum toxin injection and have also decreased ability to repair peripheral nerve damage from 
crush injury (Mizisin, Vu, Shuff, & Calcutt, 2004). Studies using GDNF-deficient mice, as well as NT-
3 deficient mice, revealed inadequate development of sympathetic and sensory neurons (Anand, 
2004), whereas knockout animals for the low-affinity NGF receptor p75NGFR showed decreased 
sensory innervation (Lee et al., 1992). Transgenic mice lacking IGF-1 show a decrease in motor and 
sensory nerve conduction velocities but no significant reduction in peripheral nerve myelination 
(Gao et al., 1998). Animals lacking ApoD revealed a decrease in motor nerve conduction 
velocityandthicknessofmyelinsheathinintactnerves,andafterinjury,axon regeneration and 
remyelination are delayed (Ganfornina et al., 2010). The 
lackofCx32,agapjunctionprotein,showedabnormallythinmyelinsheaths, reflecting myelin 
degeneration-induced Schwann cell proliferation, while nerve conductance properties are altered 
only slightly (Anzini et al., 1997). Neuropilin-2-deficient mice showed slower axonal regeneration, 
remyelination of the regenerating axons, and recovery of normal gait after a crush lesion of the 
sciatic nerve (Bannerman et al., 2008). An experiment using the Cre–loxP system to disrupt the 
laminin g1gene in Schwann cells showed that, during development, Schwann cells that lack 
laminin g1 were unabletodifferentiateandsynthesizemyelinproteins,andthereforeunableto 
myelinate axons. Moreover, after sciatic nerve crush, the axons showed 
impairedregenerationinmutantmice(Chen&Strickland,2003).Peripheral nervesdevelopandfunction 
normally inGFAP-nullmice. However, axonal regeneration after crush lesion was delayed. Mutant 
Schwann cells maintained the ability to dedifferentiate but showed defective proliferation, a key 
event for successful nerve regeneration (Triolo et al., 2006). Neurofilament light knockout mice 
develop normally, but the regeneration of myelinated axons following crush injury was found to 
be abnormal with fewer newly regenerated myelinated axons in the sciatic nerve and facial nerve 
(Zhu, Couillard-Despres, & Julien, 1997). BACE1 (b-site amyloid precursor protein cleaving enzyme 
1) knockout and wild-type nerves degenerated at a similar rate after axotomy. However, BACE1 
knockout mice had markedly enhanced clearance of axonal and myelin debris from degenerated 
fibers, accelerated axonal regeneration, and earlier reinnervation of NMJs, compared with 
controls (Farah et al., 2011). Fricker et al. (2011) used a single-neuron labeling with inducible 
Cremediated knockout animals, which enabled visualization of a subset of adult myelinated 
sensory and motoneurons in which Nrg1 was inducibly mutated by tamoxifen treatment. In 
uninjured mice, NRG1-deficient axons and the associated myelin sheath were normal, and the 
NMJ demonstrated normal apposition of presynaptic and postsynaptic components. After sciatic 
nerve crush, NRG1 ablation resulted in severe defects in remyelination: axons were either 
hypomyelinated or had no myelin sheath. NRG1-deficient axons were also found to regenerate at 
a slower rate (Fricker et al., 2011). Other studies use the overexpression of proteins in order to 
better understand the role of a certain protein and to circumvent methodological difficulties in 
drug delivery. For example, transgenic mice constitutively expressing both interleukin 6 (IL-6) and 
its receptor (IL-6R) showed accelerated regeneration of the axotomized nerve (Hirota, Kiyama, 
Kishimoto, & Taga, 1996). The overexpression of FGF-2 showed no difference in number and size 
of myelinated fibers compared to wild-type mice in intact nerves. On the other hand, 1 week after 
crush injury, the number of regenerated axons was doubled and the myelin thickness was 
significantly smaller in transgenic mice, but after 2 and 4 weeks, there were no differences in the 
recovery of sensory and motor nerve fibers, showing that FGF-2 influences early peripheral nerve 
regeneration by regulating Schwanncell proliferation, axonal regrowth, and remyelination 
(Jungnickel, Haase, Konitzer, Timmer, & Grothe, 2006). Transgenic mice expressing Nogo-C in 
peripheral Schwann cells regenerate axons less rapidly than do wild-type mice after mid-thigh 
sciatic nerve crush (Kim, Bonilla, Qiu, & Strittmatter, 2003). On the other hand, using regulated 
transgenic expression of Nogo-A in peripheral nerve Schwann cells, Pot et al. (2002) showed that 
axonal regeneration and functional recovery are impaired after a sciatic nerve crush. Finally, the 
overexpression of L1(adhesion molecule) in neurons had no effect on femoral nerve function, 
numbers of quadriceps motoneurons, and myelinated axons in injured nerves; after femoral nerve 
injury, L1 overexpression had no impact on the time course and degree of functional recovery, but 
myelination in the motor and sensory femoral nerve branches was significantly improved and loss 
of perisomatic inhibitory terminals on motoneurons was attenuated in the transgenic mice 
(Guseva et al., 2011). Recently, we showed that constitutive ErbB2 receptor overexpression 
improves nerve regeneration following traumatic injury, possibly through the upregulation of 
soluble NRG1 isoforms (Ronchi et al., 2013). 
 
6. CONCLUSIONS 
 
Recent advances in peripheral nerve regeneration research have strengthened the view that the 
process of nerve regeneration and target reinnervation is quite complex and involves several 
factors. Keeping in mind the complexity of the whole process is thus very important for improving 
our knowledge on peripheral nerve regeneration, especially in the perspective of translating basic 
science results to the clinics. Figure 8.2 synthesizes this concept: in fact, it is important, but not 
enough, to study the involvement of a single molecule, such as the NRG1/ErbB system (Ronchi et 
al., 2013) or other ligands and receptors involving in the process. It is also important, but not 
enough, to study the cell–cell interaction (in particular the interaction between regenerating 
axons and glial cells). Moreover, it is important, but not enough, to study the dynamics of the 
regenerative nerve, for example, with a tissue engineering approach and reconstructive 
microsurgery. Rather, the wholesystemmust be taken intoaccount,including not only the damaged 
nerve and all the molecules involved in the process but also the proximal plasticity that occurs 
after a peripheral injury (DRG and CNS) and the effects that an injury has on distal sites (such as 
skeletal muscle atrophy). Methods to improve the regenerative process should therefore 
simultaneously potentiate axonal regeneration, increase neuronal survival, and modulate central 
reorganization, as well as reduce muscle and sensory receptor atrophy and degeneration. It is 
expected that this holistic approach might lead to significant improvement in the functional 
outcome and thus the quality of life of the patients suffering from peripheral nerve injury. 
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